Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion +29,670 $10.36 $307K 99,592
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion +4,994 $11.10 $55K 104,586
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion +3,723 $11.97 $45K 108,309
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion +3,144 $12.97 $41K 111,453
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion +2,595 $15.52 $40K 114,048
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion · Share Option −29,670 0
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion · Share Option −4,994 54,936
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion · Share Option −3,723 56,207
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion · Share Option −3,144 38,256
2026-11-13 Paolini John F. CHIEF MEDICAL OFFICER Exercise or conversion · Share Option −2,595 47,405
2026-11-09 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion 10b5-1 +11,280 $17.76 $200K 23,977
2026-11-09 Megna Michael R CHIEF ACCOUNTING OFFICER Sale 10b5-1 −11,280 $98.54 $1.1M 12,697
2026-11-09 Megna Michael R CHIEF ACCOUNTING OFFICER Exercise or conversion · Share Option 10b5-1 −11,280 5,114
2026-11-04 Patel Sanj K CHAIRMAN & CEO Exercise or conversion 10b5-1 +145,763 $17.92 $2.6M 925,800
2026-11-04 Patel Sanj K CHAIRMAN & CEO Sale 10b5-1 −1,460 $92.35 $135K 924,340
2026-11-04 Patel Sanj K CHAIRMAN & CEO Sale 10b5-1 −11,335 $93.54 $1.1M 913,005
2026-11-04 Patel Sanj K CHAIRMAN & CEO Sale 10b5-1 −81,742 $94.20 $7.7M 831,263
2026-11-04 Patel Sanj K CHAIRMAN & CEO Sale 10b5-1 −29,845 $95.48 $2.8M 801,418
2026-11-04 Patel Sanj K CHAIRMAN & CEO Sale 10b5-1 −26,918 $96.05 $2.6M 774,500
2026-11-04 Patel Sanj K CHAIRMAN & CEO Exercise or conversion · Share Option 10b5-1 −145,763 0

Page 1 of 81 · 1,605 trades